This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
An estimated 500,000 patents were pledged under the Open COVID Pledge, with over a million more pledged under a similar Japanese effort. Like the Open COVID Pledge before it, Moderna’s pledge expressly states that it is valid only “ while the pandemic continues. Pfizer made such a vaccine. Moderna’s Pledge.
Two pharmaceutical giants of the pandemic, Moderna and BioNTech, are taking steps for increasing the manufacturing capacity for the COVID-19vaccine in Africa. Last March, Moderna announced its plan to set up a manufacturing facility in Kenya to produce messenger RNA (mRNA) vaccines, including COVID-19 shots.
To allocate COVID-19vaccines, the CDC’s Advisory Committee on Immunization Practices , the National Academies of Sciences, Engineering and Medicine (NASEM), and the WorldHealth Organization (WHO) identified ethical goals for prioritization, such as maximizing benefit and minimizing harm, mitigating health inequities, and reciprocity.
Current vaccine and treatment inequity was not inevitable. Early on in the pandemic, the WorldHealth Organization (WHO) proposed IP owners voluntarily license IP to others to ensure affordable COVID treatments. Existing international and domestic IP rules allow IP owners to voluntarily share their IP rights.
By Tara Davis and Nicola Soekoe In January 2021, the Director General of the WorldHealth Organization (WHO) observed that the world was on the brink of a “catastrophic moral failure” if wealthier nations did not ensure the equitable distribution of COVID-19vaccines.
Building on Siracusa to develop new human rights principles for public health emergencies Once again, the ICJ played a leading role in collaboration with the Global Health Law Consortium in drafting the PH Principles—released alongside the WorldHealth Assembly in May 2023.
As showed in a policy-brief by GI-ESCR , this situation might amount to a violation of the right to health under domestic constitutional and international law.
By Kayum Ahmed, Julia Bleckner, and Kyle Knight In mid-May, the WorldHealth Organization officially declared the “emergency” phase of the COVID-19 pandemic over.
As I previously discussed in October of 2020, Moderna pledged not to enforce its patents against makers of COVID-19vaccines during the pandemic. Then, in 2022, Moderna sued competing vaccine makers Pfizer and BioNTech.
Consider, for instance, the case of COVID-19vaccines. Even those relying on a new type of vaccine technology, such as mRNA vaccines , resulted from well over a decade of R&D in mRNA vaccinology and used vaccine components that were developed well before the COVID-19 pandemic began.
Judge Zione Ntaba’s contribution highlights how courts in Malawi decided cases relating to the Government’s responses to the COVID-19 pandemic , including, in particular, the provision of social security measures in parallel with lockdown measures, and the policy proposals relating to mandatory COVID-19vaccinations.
This symposium gathers reflections from leading scholars, activists, jurists, and others from around the world with respect to the recently issued Principles. Historically, Global Health Law has been permeated with colonialism and concerned with preserving travel and trade rather than protecting human dignity, health and life.
While the Principles and Guidelines on Human Rights and Public Health Emergencies (the Principles) do not make explicit reference to infodemics, the application of digital technologies in response to a public health emergency is a clear concern.
In 2016, the Assembly adopted a resolution calling for the existing worldwide health-system architecture to be strengthened with an empowered, well-governed, sustainably financed, and accountable WorldHealth Organization at its apex, and efficient, equitable, and resilient national health systems at its foundation.
The Public Health Category This category would establish a percentage to be applied to the existing supply of vaccine at a determinable point in time (e.g., an either agreed-upon or to be agreed-upon date after a transnational epidemic or pandemic is declared by a reference institution, such as the WorldHealth Organization).
During a recent Q&A, a representative with the WorldHealth Organization warned that the Omicron variant is not the last of its kind. Dr. Maria Van Kerkhove explained that the next variant is likely to be more transmissible and could be more deadly than any of the previous variants.
A little over one week later, we reported that the WorldHealth Organization declared a global health emergency after COVID-19 was detected in eighteen countries, infecting almost 10,000 people and killing more than two hundred.
Even three years on, the WorldHealth Organization found that 84% of countries were still experiencing some disruption. AI can bring benefits , including cost reduction, error avoidance, and innovative upside.
Health resources are unevenly distributed and often of poor quality. The WorldHealth Organization estimates that in the majority of African countries, there is one hospital per one million people, one doctor per 10,000 people and one hospital bed per 10,000 people.
The COVID-19 pandemic has raised unprecedented challenges for the global health framework and its long-term consequences are not yet in full sight. This post was originally published on the Verfassungsblog as part of our joint symposium on international pandemic lawmaking. By Ilja Richard Pavone.
Consider the United States, for example, which made the unprecedented move to leave the WorldHealth Organization (WHO) during the pandemic. Around the same time, it poured billions of dollars to accelerate vaccine development, without obtaining a single contractual commitment to protect global access.
They'll explain how it's now positioned to move beyond mere immunization status and toward a larger approach to interoperable health records. And they'll show how, through an upcoming collaboration with the WorldHealth Organization and the G20, those advancements can soon be expanding globally.
With rising case numbers in across the DACH (Germany, Austria and Switzerland) region and the rest of Europe, a fully vaccinated status might become compulsory for the use of the EU Digital COVID Certificate (EUDCC) soon – at least in some countries. WHY IT MATTERS. THE LARGER TREND.
All of this might make sense in a world where COVID has gradually become less prevalent and less of threat. But, if that world exists, it is somewhere in another dimension.
This week marks the two-year anniversary of WorldHealth Organization Director-General Tedros Adhanom declaring COVID-19 a pandemic. By Chloe Reichel, Marissa Mery, and Michael Ashley Stein.
On Friday, November 26, 2021, the WorldHealth Organization (“WHO”) reported a new variant of COVID-19, the Omicron variant, was detected in South Africa. There is no indication the new variant is more contagious or more lethal, or that it is resistant to the COVID-19vaccine.
By the end of 2021, about 4 billion COVID-19vaccine doses will be delivered globally. They aim to deliver 2 billion doses by the end of 2021 equitably amongst all the 172 participating countries, resulting in around 25% of the global population getting vaccinated.
The phenomenon of medical mis-information accelerated during the COVID-19 pandemic, normalizing weird anti-science and culminating in the rejection among many U.S. health citizens of the vaccine fast-tracked to address the worst effects of the coronavirus. KFF fielded the study in May and June 2023, finding that most U.S.
Since the WorldHealth Organization (WHO) declared the Covid-19 pandemic in March 2020, the rate of reporting of safety data has been unprecedented with the EMA reporting a 93% increase in the volume of adverse event reports reported in 2021 compared to 2020 1. . New advances in technology (e.g.,
Commission Extends Transparency and Authorization Mechanism for Exports of COVID-19Vaccines, 11 March 2021. The EC has extended until the end of June 2021 the transparency and authorization mechanism for COVID-19vaccine exports. The EU continues to be the leading provider of vaccines around the world.
An employee is considered “fully vaccinated” two weeks after completing primary vaccination with a COVID-19vaccine with, if applicable, at least the minimum interval between doses as recommended by the CDC, WorldHealth Organization (“WHO”), or if administered as a part of a clinical trial.
the principles encourage international cooperation, “including measures for technical and economic cooperation, and equitable access to health goods, facilities, services and technologies.” The WorldHealth Organizations (WHO) agreements are central in this context.” For example, in Article 2.2,
The Argentine case: suspension of pediatric vaccinationCOVID-19 On November 30, 2022, Federal Court No. 4 of Mar del Plata decided the case “Carrillo Couhez, María Alicia Noemí and Others v/ National Executive Power and others/ Collective Amparo” (File No. SB/LC/JGI/VC 14056/2022).
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content